A Cochrane review found no evidence to support or reject the use of ovarian reserve tests to determine a personalised dose of drugs for ovarian stimulation during IVF.
The review included 26 studies involving 8520 women, and found low or very low certainty of evidence due to a lack of double-blind clinical trials, and small sample sizes.
No evidence to support or reject personalised ovarian stimulation doses
Image by Alan Handyside via the Wellcome Collection. Depicts equipment used for embryo biopsy.
